Rs 1,940 Puts — 0.5% Below Current Price — Draw 2,707 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

The put contracts expiring on 25 August 2026 at the Rs 1,940 strike saw a turnover of approximately ₹291.25 lakhs, with open interest standing at 845 contracts. The number of contracts traded is more than three times the open interest, indicating significant fresh activity rather than mere position adjustments. Meanwhile, the underlying stock closed flat on the day, having recently hit a new 52-week high of Rs 2,046.9. The stock has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a strong technical uptrend. Is this put activity a sign of cautious protection or a subtle bearish bet?

Strike Price Analysis: Moneyness and Distance

The Rs 1,940 strike sits just 0.5% below the current market price of Rs 1,950, placing these puts slightly in-the-money (ITM). This proximity suggests that the put buyers are not targeting a deep downside but rather a near-term buffer against a modest pullback. The closeness to the underlying price is a critical clue: if these were far out-of-the-money (OTM) puts, the interpretation might lean more towards speculative bearish bets or put writing. Instead, the near-ATM/ITM nature of these puts points towards a protective stance, possibly hedging existing long positions in a stock that has recently rallied strongly.

Interpreting the Put Activity: Hedging, Bearish Positioning, or Put Writing?

Put options inherently carry ambiguous signals. They can represent bearish bets if bought outright, protective hedges if purchased to guard gains, or bullish put writing if sold to collect premium. In this case, the Rs 1,940 puts’ slight ITM status combined with the stock’s recent strength and flat daily close suggests hedging is the dominant motive. The stock’s recent rally to a 52-week high and its position above all major moving averages make a sharp decline less likely, reducing the attractiveness of directional bearish bets. Put writing is less probable here given the high turnover relative to open interest, which indicates fresh buying rather than premium collection. Could this be a case of investors protecting profits amid a strong uptrend?

Open Interest and Contracts Analysis

The ratio of contracts traded (2,707) to open interest (845) is roughly 3.2:1, signalling a surge in new positions rather than just rollovers or unwinding. This fresh activity at a strike close to the current price suggests investors are actively seeking downside protection rather than merely adjusting existing positions. The relatively modest open interest compared to the volume traded also implies that the market is still building this put position, which aligns with a cautious hedging approach rather than aggressive bearish speculation.

Cash Market Momentum and Technical Alignment

Sun Pharmaceutical Industries Ltd has been on a steady upward trajectory, trading above all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day. This broad technical strength supports the view that the put activity is more likely protective hedging than outright bearish positioning. The stock’s recent intraday high of Rs 2,046.9 contrasts with the Rs 1,940 put strike, which is positioned near a technical support zone just below the current price. This suggests investors may be guarding against a mild retracement rather than a sharp sell-off. Delivery volumes have risen modestly by 1% against the 5-day average, indicating sustained investor participation, though the weighted average price skewed towards the day’s low, hinting at some profit booking pressure. Does this technical picture confirm a cautious but confident market stance?

Delivery Volume and Market Participation

Delivery volume on 31 July was 26.41 lakh shares, up 1% from the recent average, reflecting steady investor interest. The stock’s liquidity supports sizeable trades, with a 2% average traded value equating to roughly ₹16.63 crores, ensuring that the options activity is backed by a liquid cash market. The combination of rising delivery volumes and strong moving averages suggests that the put activity is more consistent with hedging existing long positions rather than speculative bearish bets or put writing strategies.

Conclusion: Protective Hedging Dominates Put Activity

The put option activity at the Rs 1,940 strike on Sun Pharmaceutical Industries Ltd appears to be primarily driven by protective hedging rather than outright bearish bets or put writing. The strike’s proximity to the current price, the stock’s strong technical position above all major moving averages, and the fresh surge in contracts relative to open interest all point towards investors seeking to shield gains amid a recent rally. While the possibility of some directional bearish positioning cannot be entirely ruled out, the data favours a cautious approach to risk management in a large-cap stock trading near its highs. Should investors consider similar protective strategies or interpret this as a sign of underlying caution?

Options involve risk and are not suitable for all investors. The interpretations presented are based on available data and do not constitute investment advice.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →